Spencer C. Wei

11.3k total citations · 3 hit papers
14 papers, 4.5k citations indexed

About

Spencer C. Wei is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Spencer C. Wei has authored 14 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Spencer C. Wei's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers) and Bacteriophages and microbial interactions (2 papers). Spencer C. Wei is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (5 papers) and Bacteriophages and microbial interactions (2 papers). Spencer C. Wei collaborates with scholars based in United States, China and Macao. Spencer C. Wei's co-authors include James P. Allison, Colm R. Duffy, Jing Yang, Dana Pe’er, Nana-Ama A.S. Anang, Jacob Levine, Miles C. Andrews, Alexandria P. Cogdill, Jennifer A. Wargo and Yang Zhao and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Spencer C. Wei

13 papers receiving 4.5k citations

Hit Papers

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy 2015 2026 2018 2022 2018 2017 2015 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spencer C. Wei United States 10 3.0k 2.0k 1.1k 593 533 14 4.5k
Michael W. Pickup United States 22 1.9k 0.6× 929 0.5× 1.8k 1.6× 416 0.7× 812 1.5× 32 4.0k
Neta Erez Israel 35 3.1k 1.0× 1.9k 1.0× 2.6k 2.3× 710 1.2× 300 0.6× 61 5.7k
Tobias Schatton United States 27 3.1k 1.0× 1.4k 0.7× 2.2k 2.0× 289 0.5× 344 0.6× 40 4.4k
David A. Barbie United States 30 2.2k 0.7× 1.4k 0.7× 2.7k 2.4× 630 1.1× 255 0.5× 81 5.0k
Ilaria Malanchi United Kingdom 26 2.5k 0.8× 1.3k 0.7× 2.6k 2.3× 457 0.8× 772 1.4× 44 5.4k
Carola H. Ries Germany 25 1.7k 0.5× 2.0k 1.0× 1.3k 1.2× 566 1.0× 120 0.2× 38 3.7k
Maja H. Oktay United States 32 1.7k 0.6× 893 0.5× 1.5k 1.3× 309 0.5× 492 0.9× 84 3.5k
Viviana Cremasco United States 22 1.6k 0.5× 1.4k 0.7× 1.2k 1.1× 391 0.7× 128 0.2× 31 3.3k
Viola Heinzelmann‐Schwarz Switzerland 29 1.8k 0.6× 848 0.4× 1.9k 1.7× 375 0.6× 274 0.5× 120 4.2k
Todd D. Prickett United States 34 4.0k 1.3× 3.2k 1.6× 2.3k 2.1× 307 0.5× 290 0.5× 52 5.9k

Countries citing papers authored by Spencer C. Wei

Since Specialization
Citations

This map shows the geographic impact of Spencer C. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer C. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer C. Wei more than expected).

Fields of papers citing papers by Spencer C. Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer C. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer C. Wei. The network helps show where Spencer C. Wei may publish in the future.

Co-authorship network of co-authors of Spencer C. Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer C. Wei. A scholar is included among the top collaborators of Spencer C. Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer C. Wei. Spencer C. Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yang, Yongqing, Ziqiang Liu, Shuai Lü, et al.. (2025). A case report of bacteriophage therapy for the treatment of lung infection due to carbapenem-resistant Pseudomonas aeruginosa. Scientific Reports. 15(1). 33512–33512. 1 indexed citations
2.
Liu, Ziqiang, Shuai Lü, Yongqing Yang, et al.. (2025). Efficacy of precisely tailored phage cocktails targeting carbapenem-resistant Acinetobacter baumannii reveals evolutionary trade-offs: a proof-of-concept study. EBioMedicine. 120. 105942–105942. 1 indexed citations
3.
Gowen, Benjamin G., Jean L. Chan, Aaron J. Cantor, et al.. (2024). Identification of a Guide RNA Targeting an Ultraconserved Element for Evaluation of Cas9 Genome Editors Across Mammalian Species. The CRISPR Journal. 7(6). 306–309.
4.
Ma, Ying, Jun Li, Huamin Wang, et al.. (2020). Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Gastroenterology. 159(1). 306–319.e12. 107 indexed citations
5.
Wei, Spencer C., Roshan Sharma, Nana-Ama A.S. Anang, et al.. (2019). Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States. Immunity. 50(4). 1084–1098.e10. 68 indexed citations
6.
Wei, Spencer C., Nana-Ama A.S. Anang, Roshan Sharma, et al.. (2019). Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies. Proceedings of the National Academy of Sciences. 116(45). 22699–22709. 226 indexed citations
7.
Gregus, Ann M., Matthew W. Buczynski, Darren S. Dumlao, et al.. (2018). Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug–unresponsive hyperalgesia in male rats. Pain. 159(12). 2620–2629. 12 indexed citations
8.
Wei, Spencer C., Colm R. Duffy, & James P. Allison. (2018). Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discovery. 8(9). 1069–1086. 2200 indexed citations breakdown →
9.
Wei, Spencer C., Jacob Levine, Alexandria P. Cogdill, et al.. (2017). Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell. 170(6). 1120–1133.e17. 928 indexed citations breakdown →
10.
Wei, Spencer C., Jacob Levine, Dana Pe’er, & James P. Allison. (2017). Abstract 592: Distinct cellular mechanisms mediate anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cancer Research. 77(13_Supplement). 592–592. 1 indexed citations
11.
Wei, Spencer C. & Jing Yang. (2015). Forcing through Tumor Metastasis: The Interplay between Tissue Rigidity and Epithelial–Mesenchymal Transition. Trends in Cell Biology. 26(2). 111–120. 170 indexed citations
12.
Wei, Spencer C., Laurent Fattet, Jeff H. Tsai, et al.. (2015). Matrix stiffness drives epithelial–mesenchymal transition and tumour metastasis through a TWIST1–G3BP2 mechanotransduction pathway. Nature Cell Biology. 17(5). 678–688. 710 indexed citations breakdown →
13.
Gregus, Ann M., Darren S. Dumlao, Spencer C. Wei, et al.. (2013). Systematic analysis of rat 12/15‐lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia. The FASEB Journal. 27(5). 1939–1949. 41 indexed citations
14.
Blanvillain, Robert, Spencer C. Wei, Pengcheng Wei, Jong H. Kim, & David W. Ow. (2011). Stress tolerance to stress escape in plants: role of the OXS2 zinc‐finger transcription factor family. The EMBO Journal. 30(18). 3812–3822. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026